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Incidence of Stent Thrombosis With Bioresorbable Vascular Scaffolds In Comparison With Drug-Eluting Stents
In evaluating the effectiveness of bioresorbable vascular scaffolds (BVS) in comparison with traditional drug-eluting stents (DES), the ABSORB China trial (1) found a remarkably low incidence of stent thrombosis in both treatment arms. This finding, however, differs to some extent from that found in other randomized trials aimed at this comparison.
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